Intezyne announces creative patents covering IVECT Method in biggest pharmaceutical markets
Posted in Medical Patent on January 6th, 2010Intezyne today announced the issuance of fresh patents that envelop multiple dimensions of the Company’s mutinous technology rostrum, the IVECTTM Method, in the important pharmaceutical markets of the Coordinated States, Europe, and Japan. All patents are hook owned as a rule Intezyne.
“Intezyne has captivated a stronger and broader predication in medicine distribution and PEGylation technology be means Read the rest of this entry »
